Trial Profile
To evaluate the efficacy and safety of Reditux TM in patients with moderate to severe Rheumatoid arthritis who failed therapy with disease-modifying anti-rheumatic drugs: A retrospective analysis of real world use
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2017
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2017 New trial record